Tranzyme Pharma and Norgine Announce Top-line Data from ULISES 007, the First of Two Phase 3 Pivotal Trials
Mar 12, 2012 at 8:00 AM ET
Registration is required to listen to this webcast. * Required fields
** An email will be sent to your email address confirming your identity. You will then be given options to sign up for webcast and other alerts.










